[{"address1": "5 Science Park", "address2": "395 Winchester Avenue", "city": "New Haven", "state": "CT", "zip": "06511", "country": "United States", "phone": "203 535 1456", "website": "https://www.arvinas.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company engineers proteolysis targeting chimeras (PROTAC) targeted protein degraders that are designed to harness the body's own natural protein disposal system to degrade and remove disease-causing proteins. Its product pipeline includes Bavdegalutamide and ARV-766, investigational orally bioavailable PROTAC protein degraders for the treatment of men with metastatic castration-resistant prostate cancer, which are in Phase 3 clinical trials; and ARV-471, an orally bioavailable estrogen receptor degrading PROTAC targeted protein degrader for the treatment of patients with locally advanced or metastatic estrogen receptor+/human epidermal growth factor receptor 2-breast cancer, which is Phase 3 clinical trial. The company's products also consists ARV 393, orally bioavailable PROTAC designed to degrade BCL6, a transcriptional repressor and a key regulator of normal B-cell maturation and differentiation processes which is in Phase 1 first-in-human clinical trial; ARV 102 for the treatment of neurodegenerative diseases, which is in Phase 1 clinical trial; and KRAS G12D program is in preclinical development for pancreatic and colorectal cancers. Arvinas, Inc. has collaborations with Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., Carrick Therapeutics Limited, and Bayer AG. The company was founded in 2013 and is based in New Haven, Connecticut.", "fullTimeEmployees": 430, "companyOfficers": [{"maxAge": 1, "name": "Dr. John G. Houston Ph.D.", "age": 64, "title": "Chairperson, CEO & President", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 1124624, "exercisedValue": 0, "unexercisedValue": 847759}, {"maxAge": 1, "name": "Mr. Andrew R. Saik", "age": 55, "title": "CFO & Treasurer", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 657193, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Angela M. Cacace Ph.D.", "age": 56, "title": "Chief Scientific Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 696153, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ian  Taylor Ph.D.", "age": 61, "title": "Consultant", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 553937, "exercisedValue": 209766, "unexercisedValue": 39891}, {"maxAge": 1, "name": "Dr. Randy  Teel Ph.D.", "age": 44, "title": "Chief Business Officer", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 711098, "exercisedValue": 0, "unexercisedValue": 331598}, {"maxAge": 1, "name": "Dr. Noah  Berkowitz M.D., Ph.D.", "age": 60, "title": "Chief Medical Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 747020, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David K. Loomis M.B.A.", "age": 50, "title": "VP & Chief Accounting Officer", "yearBorn": 1974, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jared M. Freedberg J.D.", "age": 55, "title": "General Counsel & Corporate Secretary", "yearBorn": 1969, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Steve  Weiss", "age": 54, "title": "Senior VP & Chief Human Resources Officer", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lisa  Sinclair", "title": "Senior Vice President of Corporate Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 3, "boardRisk": 9, "compensationRisk": 8, "shareHolderRightsRisk": 9, "overallRisk": 8, "governanceEpochDate": 1748736000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.44, "open": 7.36, "dayLow": 7.09, "dayHigh": 7.445, "regularMarketPreviousClose": 7.44, "regularMarketOpen": 7.36, "regularMarketDayLow": 7.09, "regularMarketDayHigh": 7.445, "payoutRatio": 0.0, "beta": 2.201, "forwardPE": -1.5879829, "volume": 1248284, "regularMarketVolume": 1248284, "averageVolume": 2690882, "averageVolume10days": 2113460, "averageDailyVolume10Day": 2113460, "bid": 7.35, "ask": 7.5, "bidSize": 20, "askSize": 20, "marketCap": 540136384, "fiftyTwoWeekLow": 5.9, "fiftyTwoWeekHigh": 34.11, "priceToSalesTrailing12Months": 1.2652527, "fiftyDayAverage": 7.429, "twoHundredDayAverage": 16.93075, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -403663712, "profitMargins": -0.109160006, "floatShares": 63152881, "sharesOutstanding": 72991400, "sharesShort": 7730211, "sharesShortPriorMonth": 7399181, "sharesShortPreviousMonthDate": 1745971200, "dateShortInterest": 1748563200, "sharesPercentSharesOut": 0.105900005, "heldPercentInsiders": 0.067490004, "heldPercentInstitutions": 0.91082, "shortRatio": 2.44, "shortPercentOfFloat": 0.1076, "impliedSharesOutstanding": 72991400, "bookValue": 9.042, "priceToBook": 0.818403, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -46600000, "trailingEps": -0.66, "forwardEps": -4.66, "enterpriseToRevenue": -0.946, "enterpriseToEbitda": 4.416, "52WeekChange": -0.69746524, "SandP52WeekChange": 0.10163462, "quoteType": "EQUITY", "currentPrice": 7.4, "targetHighPrice": 110.0, "targetLowPrice": 8.0, "targetMeanPrice": 19.36111, "targetMedianPrice": 15.0, "recommendationMean": 2.04762, "recommendationKey": "buy", "numberOfAnalystOpinions": 18, "totalCash": 954300032, "totalCashPerShare": 13.074, "ebitda": -91400000, "totalDebt": 10500000, "quickRatio": 4.499, "currentRatio": 4.578, "totalRevenue": 426900000, "debtToEquity": 1.591, "revenuePerShare": 5.921, "returnOnAssets": -0.05393, "returnOnEquity": -0.0734, "grossProfits": 426900000, "freeCashflow": -2687500, "operatingCashflow": -250700000, "revenueGrowth": 6.462, "grossMargins": 1.0, "ebitdaMargins": -0.2141, "operatingMargins": 0.37818, "financialCurrency": "USD", "symbol": "ARVN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1538055000000, "regularMarketChange": -0.04, "regularMarketDayRange": "7.09 - 7.445", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2690882, "fiftyTwoWeekLowChange": 1.5, "fiftyTwoWeekLowChangePercent": 0.2542373, "fiftyTwoWeekRange": "5.9 - 34.11", "fiftyTwoWeekHighChange": -26.710001, "fiftyTwoWeekHighChangePercent": -0.7830548, "fiftyTwoWeekChangePercent": -69.74652, "earningsTimestamp": 1746097224, "earningsTimestampStart": 1753705800, "earningsTimestampEnd": 1754051400, "earningsCallTimestampStart": 1746100800, "earningsCallTimestampEnd": 1746100800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.66, "epsForward": -4.66, "epsCurrentYear": -1.42536, "priceEpsCurrentYear": -5.191671, "fiftyDayAverageChange": -0.028999805, "fiftyDayAverageChangePercent": -0.0039035948, "marketState": "PRE", "corporateActions": [], "regularMarketTime": 1750708802, "exchange": "NMS", "messageBoardId": "finmb_243040896", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Arvinas, Inc.", "regularMarketChangePercent": -0.537634, "regularMarketPrice": 7.4, "longName": "Arvinas, Inc.", "twoHundredDayAverageChange": -9.53075, "twoHundredDayAverageChangePercent": -0.56292546, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.0 - Buy", "cryptoTradeable": false, "displayName": "Arvinas", "trailingPegRatio": null, "__fetch_time": "2025-06-24"}]